Page 153 - 2021_10-Haematologica-web

Evolution of ISFN to aggressive B-cell lymphoma
plexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lym- phoma. Leukemia. 2014;28(5):1103-1112.
15. Schmidt J, Ramis-Zaldivar JE, Bonzheim I, et al. CREBBP gene mutations are frequently detected in in situ follicular neoplasia. Blood. 2018;132(25):2687-2690.
16. Mamessier E, Song JY, Eberle FC, et al. Early lesions of follicular lymphoma: a genetic perspective. Haematologica. 2014;99(3):481- 488.
17. Agopian J, Navarro JM, Gac AC, et al. Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med. 2009;206(7):1473-1483.
18. Mamessier E, Drevet C, Broussais- Guillaumot F, et al. Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites. Haematologica. 2015;100(4): e155-157.
19. Kosmidis P, Bonzheim I, Dufke C, et al. Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follic- ular neoplasia. PLoS One. 2017;12(6): e0178503.
20. Coelho V, Krysov S, Ghaemmaghami AM, et al. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A. 2010;107 (43):18587-18592.
21. Greeve J, Philipsen A, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 2003;101(9):3574-3580.
22. Loeffler M, Kreuz M, Haake A, et al. Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia. 2015;29(2):456-463.
23. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298-303.
24. Aukema SM, Kreuz M, Kohler CW, et al. Biological characterization of adult MYC- translocation-positive mature B-cell lym- phomas other than molecular Burkitt lym- phoma. Haematologica. 2014;99(4):726-735.
25. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoprolifera- tions: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
26. Lee AY, Connors JM, Klimo P, O'Reilly SE,
Gascoyne RD. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. J Clin Oncol. 1997;15(5):1745- 1753.
27.Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005;29(12):1549-1557.
28. Brudno J, Tadmor T, Pittaluga S, Nicolae A, Polliack A, Dunleavy K. Discordant bone marrow involvement in non-Hodgkin lym- phoma. Blood. 2016;127(8):965-970.
29. Kremer M, Spitzer M, Mandl-Weber S, et al. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Invest. 2003;83(1): 107-114.
30. Schmitz R, Wright GW, Huang DW, et al. Genetics and pathogenesis of diffuse large B- cell lymphoma. N Engl J Med. 2018;378 (15):1396-1407.
31. Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct path- ogenic mechanisms and outcomes. Nat Med. 2018;24(5):679-690.
32. Yamamoto K, Okamura A, Inui Y, et al. Cryptic insertion of BCL2 gene into immunoglobulin heavy locus in follicular lymphoma with t(6;9)(p23;p13). Leuk Res. 2012;36(9):e202-205.
33. Bonzheim I, Salaverria I, Haake A, et al. A unique case of follicular lymphoma provides insights to the clonal evolution from follicu- lar lymphoma in situ to manifest follicular lymphoma. Blood. 2011;118(12):3442-3444.
34. Juskevicius D, Lorber T, Gsponer J, et al. Distinct genetic evolution patterns of relaps- ing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 2016;30(12):2385-2395.
35. Weigert O, Kopp N, Lane AA, et al. Molecular ontogeny of donor-derived follic- ular lymphomas occurring after hematopoi- etic cell transplantation. Cancer Discov. 2012;2(1): 47-55.
36. Araf S, Wang J, Ashton-Key M, et al. Transmission of diffuse large B-cell lym- phoma by an allogeneic stem-cell transplant. Haematologica. 2019;104(4):e174-e177.
37. Okosun J, Bodor C, Wang J, et al. Integrated genomic analysis identifies recurrent muta- tions and evolution patterns driving the ini- tiation and progression of follicular lym-
phoma. Nat Genet. 2014;46(2):176-181.
38. Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transfor-
mation. Cell Rep. 2014;6(1):130-140.
39. Saito M, Novak U, Piovan E, et al. BCL6 sup- pression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl
Acad Sci U S A. 2009;106(27):11294-11299. 40. Schuetz JM, Johnson NA, Morin RD, et al. BCL2 mutations in diffuse large B-cell lym-
phoma. Leukemia. 2012;26(6):1383-1390. 41. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet. 2008;40(1):
108-112.
42. Sungalee S, Mamessier E, Morgado E, et al.
Germinal center reentries of BCL2-overex- pressing B cells drive follicular lymphoma progression. J Clin Invest. 2014;124(12): 5337-5351.
43. Cheung MC, Bailey D, Pennell N, et al. In situ localization of follicular lymphoma: evi- dence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node. Leukemia. 2009;23(6):1176-1179.
44. Green MR, Gentles AJ, Nair RV, et al. Hierarchy in somatic mutations arising dur- ing genomic evolution and progression of follicular lymphoma. Blood. 2013;121(9): 1604-1611.
45. Green MR, Kihira S, Liu CL, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presen- tation. Proc Natl Acad Sci U S A. 2015;112 (10):E1116-1125.
46. Kridel R, Chan FC, Mottok A, et al. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med. 2016;13(12):e1002197.
47. Pasqualucci L, Dominguez-Sola D, Chiarenza A, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011;471(7337):189-195.
48. Zhang J, Vlasevska S, Wells VA, et al. The CREBBP acetyltransferase is a haploinsuffi- cient tumor suppressor in B-cell lymphoma. Cancer Discov. 2017;7(3):322-337.
49. Jiang Y, Redmond D, Nie K, et al. Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas. Genome Biol. 2014;15(8):432.
50. Correia C, Schneider PA, Dai H, et al. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood. 2015;125(4): 658-667.
haematologica | 2021; 106(10)
2681